Literature DB >> 2021592

Influence of genotype on the natural history of untreated proliferative sickle retinopathy--an angiographic study.

P D Fox1, S J Vessey, M L Forshaw, G R Serjeant.   

Abstract

The natural history of untreated proliferative sickle retinopathy (PSR) has been observed in 35 patients (40 eyes) with homozygous sickle cell (SS) disease and in 112 patients (114 eyes) with sickle cell-haemoglobin C (SC) disease over a mean follow-up period of 4.5 years (range 0.5-14.0 years). In both genotypes progression of PSR was most frequent between ages 20 and 39 years. Spontaneous regression was more common in SS disease (p = 0.01), and more likely to proceed to complete non-perfusion. In SC disease PSR tended to be stable in patients aged 40 and over, and non-perfused PSR lesions were significantly more likely to reperfuse (p = 0.01) than in SS disease. In both genotypes regression was not influenced by size or elevation of the PSR lesion. The tendency for PSR to regress in SS disease suggests that treatment is unnecessary in SS patients aged 40 and over.

Entities:  

Mesh:

Year:  1991        PMID: 2021592      PMCID: PMC1042329          DOI: 10.1136/bjo.75.4.229

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  18 in total

1.  The progression of sickle cell eye disease in Jamaica.

Authors:  P I Condon; G R Serjeant
Journal:  Doc Ophthalmol       Date:  1975-11-21       Impact factor: 2.379

2.  Choroido-vitreal neovascularization after argon laser photocoagulation.

Authors:  S O Galinos; G K Asdourian; M B Woolf; M F Goldberg; B J Busse
Journal:  Arch Ophthalmol       Date:  1975-07

3.  Estimation of small percentages of foetal haemoglobin.

Authors:  K BETKE; H R MARTI; I SCHLICHT
Journal:  Nature       Date:  1959-12-12       Impact factor: 49.962

4.  Spontaneous regression (autoinfarction) of proliferative sickle retinopathy.

Authors:  K C Nagpal; D Patrianakos; G K Asdourian; M F Goldberg; M Rabb; L Jampol
Journal:  Am J Ophthalmol       Date:  1975-11       Impact factor: 5.258

5.  Cryotherapy of proliferative sickle retinopathy. Part I. Single freeze-thaw cycle.

Authors:  C B Lee; M B Woolf; S O Galinos; M H Goldbaum; T S Stevens; M F Goldberg
Journal:  Ann Ophthalmol       Date:  1975-10

6.  Photocoagulation and diathermy in the treatment of proliferative sickle retinopathy.

Authors:  P I Condon; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1974-07       Impact factor: 4.638

7.  Argon laser photocoagulation of proliferative sickle retinopathy.

Authors:  M F Goldberg; I Acacio
Journal:  Arch Ophthalmol       Date:  1973-07

8.  Ocular findings in hemoglobin SC disease in Jamaica.

Authors:  P I Condon; G R Serjeant
Journal:  Am J Ophthalmol       Date:  1972-11       Impact factor: 5.258

9.  Natural history of untreated proliferative sickle retinopathy.

Authors:  M F Goldberg
Journal:  Arch Ophthalmol       Date:  1971-04

10.  Behaviour of untreated proliferative sickle retinopathy.

Authors:  P I Condon; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1980-06       Impact factor: 4.638

View more
  4 in total

1.  The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment.

Authors:  J S Mohan; P L Lip; A D Blann; D Bareford; G Y H Lip
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

2.  Development of a New Adult Sickle Cell Disease Center Within an Academic Cancer Center: Impact on Hospital Utilization Patterns and Care Quality.

Authors:  Biree Andemariam; Sasia Jones
Journal:  J Racial Ethn Health Disparities       Date:  2015-07-21

3.  Action on sickle cell retinopathy: the time is now.

Authors:  Christiana Dinah; Brigit Greystoke; Isabella Mueller; James Talks
Journal:  Eye (Lond)       Date:  2022-01-28       Impact factor: 4.456

Review 4.  Laser therapy for retinopathy in sickle cell disease.

Authors:  Kay Thi Myint; Soumendra Sahoo; Aung Win Thein; Soe Moe; Han Ni
Journal:  Cochrane Database Syst Rev       Date:  2015-10-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.